<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2025, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 03 Feb 2025 15:50:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>EvokAI Creative Labs Sets Date for Share Consolidation</title>
   <link>http://www.streetinsider.com/Press+Releases/EvokAI+Creative+Labs+Sets+Date+for+Share+Consolidation/24286475.html</link>
   <description>
      &lt;p&gt;&lt;strong&gt;VANCOUVER, BC / &lt;/strong&gt;&lt;a href=&quot;https://www.accessnewswire.com/&quot; rel=&quot;nofollow&quot;&gt;&lt;strong&gt;ACCESS Newswire&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt; / February 3, 2025 /&lt;/strong&gt; EvokAI Creative Labs Inc. (&lt;strong&gt;TSXV:OKAI)(OTCQB:OKAIF&lt;/strong&gt;) (&quot;&lt;strong&gt;EvokAI&lt;/strong&gt;&quot; or the &quot;&lt;strong&gt;Company&lt;/strong&gt;&quot;), a leading MedTech AI-powered company dedicated to the development of transformational and innovative technologies for the healthcare sector, further to its press release on December 17, 2024, announces that it will complete the previously announced consolidation of its issued and outstanding common shares on a 10:1 basis (the &quot;&lt;strong&gt;Consolidation&lt;/strong&gt;&quot;), effective at the opening of the market on Wednesday, February 05, 2025. Subject to the Consolidation, the Company will have approximately 7,605,493 common shares</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EvokAI+Creative+Labs+Sets+Date+for+Share+Consolidation/24286475.html</guid>
   <pubDate>Mon, 03 Feb 2025 15:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">OKAIF</category>
   	  </item>
  <item>
   <title>EvokAI Creative Labs Sets Date for Share Consolidation</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/EvokAI+Creative+Labs+Sets+Date+for+Share+Consolidation/24286475.html</link>
   <description>
      &lt;p&gt;&lt;strong&gt;VANCOUVER, BC / &lt;/strong&gt;&lt;a href=&quot;https://www.accessnewswire.com/&quot; rel=&quot;nofollow&quot;&gt;&lt;strong&gt;ACCESS Newswire&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt; / February 3, 2025 /&lt;/strong&gt; EvokAI Creative Labs Inc. (&lt;strong&gt;TSXV:OKAI)(OTCQB:OKAIF&lt;/strong&gt;) (&quot;&lt;strong&gt;EvokAI&lt;/strong&gt;&quot; or the &quot;&lt;strong&gt;Company&lt;/strong&gt;&quot;), a leading MedTech AI-powered company dedicated to the development of transformational and innovative technologies for the healthcare sector, further to its press release on December 17, 2024, announces that it will complete the previously announced consolidation of its issued and outstanding common shares on a 10:1 basis (the &quot;&lt;strong&gt;Consolidation&lt;/strong&gt;&quot;), effective at the opening of the market on Wednesday, February 05, 2025. Subject to the Consolidation, the Company will have approximately 7,605,493 common shares</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/EvokAI+Creative+Labs+Sets+Date+for+Share+Consolidation/24286475.html</guid>
   <pubDate>Mon, 03 Feb 2025 15:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">OKAIF</category>
   	  </item>
 </channel>
</rss>
